Inasmuch as this survey is entirely subjective, use whatever criteria you consider relevant to the question at hand. The answer choices (in alphabetical order) are:
a) Bapineuzumab (ELN/JNJ/PFE) b) Benlysta (GSK/HGSI) c) Bydureon (AMLN/BMY/AZN) d) Endostatin (ENMD) e) Exubera (PFE/NKTR) f) Provenge (DNDN) g) Rogaine (PFE/Upjohn) h) Tredaptive (MRK)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.